Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

BACKGROUNDS: Clinical evidence of the preventive effectiveness of medium-class topical corticosteroids for capecitabine-induced hand foot syndrome (HFS) is limited. Although the pathogenesis and mechanism of HFS are unclear, inflammatory reactions are thought to be involved in HFS development. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Iimura, Yohei, Furukawa, Naoki, Ishibashi, Masaaki, Ahiko, Yuka, Tanabe, Taro, Aikou, Susumu, Shida, Dai, Nojima, Masanori, Kuroda, Seiichiro, Boku, Narikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284769/
https://www.ncbi.nlm.nih.gov/pubmed/35836104
http://dx.doi.org/10.1186/s12876-022-02411-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284769/
https://www.ncbi.nlm.nih.gov/pubmed/35836104
http://dx.doi.org/10.1186/s12876-022-02411-w

Ejemplares similares